PDEX - NASDAQ

Pro-Dex, Inc.

PDEX·NASDAQ

$66.88

-1.2%

HealthcareMedical - Instruments & Supplies

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$213.52M

EPS2.7300

P/E Ratio24.50

Earnings Date07/08/2026

61.19M

Assets

17%

3Y+25.0%

5Y+97.0%

10Y+449.0%

24.56M

Total Liabilities

14%

3Y+4.0%

5Y+104.0%

10Y+982.0%

36.63M

Total Equity

19%

3Y+44.0%

5Y+92.0%

10Y+313.0%

Pro-Dex, Inc. Funding & Solvency Profile

PDEX · NASDAQ

Current Assets

Cash & Cash Equivalents419.00K

Net Receivables17.49M

Inventory22.21M

Other Current Assets434.00K

Total Current Assets47 M

Non-Current Assets

Property, Plant & Equipment1.05M

Goodwill & Intangible Assets26.00K

Long-Term Investments148.00K

Other Non-Current Assets11.26M

Total Non-Current Assets12 M

Total Assets

61.19M

Financial Health Analysis

Current Ratio

3.23x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.67x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

33 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

77% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Pro-Dex, Inc. Balance Sheet

PDEX • NASDAQ

Pro-Dex, Inc. Balance Sheet	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Jun 2015	Jun 2014	Jun 2013	Jun 2012	Jun 2011	Jun 2010	Jun 2009	Jun 2008	Jun 2007	Jun 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	419K	2.6M	2.9M	849K	849K	6.4M	7.7M	5.2M	4.2M	2.3M	697K	3.2M	1.7M	4.1M	4.7M	3.8M	1.1M	517K	403K	358K
Short-Term Investments	6.7M	4.2M	1.1M	755K	755K	2.6M	2.6M	2.2M	718K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	7.2M	6.8M	4.1M	1.6M	1.6M	9M	10.4M	7.4M	4.9M	2.3M	697K	3.2M	1.7M	4.1M	4.7M	3.8M	1.1M	517K	403K	358K
Net Receivables	17.5M	13.9M	10M	15.4M	15.4M	5.2M	4.1M	4.1M	3.6M	3M	3.2M	2.9M	1.6M	2.3M	3.1M	2.7M	2.5M	3M	3.4M	4.1M
Accounts Receivables	16.4M	13.9M	10M	15.4M	15.4M	5.2M	4.1M	3M	3.5M	2.9M	3.2M	1.8M	1.3M	1.6M	3.1M	2.7M	2.5M	2.8M	3.4M	3.8M
Other Receivables	1.1M	0.0	0.0	0.0	0.0	0.0	0.0	1.2M	86K	91K	28K	1.1M	278K	123K	12K	22K	16K	205K	0.0	222K
Inventory	22.2M	15.3M	16.2M	12.7M	12.7M	8.2M	6.2M	4.4M	3.1M	3.6M	4.3M	2.6M	3.8M	2.8M	3.7M	3.2M	3.4M	5.1M	4.6M	4M
Prepaids	0.0	345K	296K	790K	790K	145K	623K	269K	277K	129K	124K	110K	157K	172K	145K	174K	235K	1.1M	205K	91K
Other Current Assets	434K	262K	494K	710K	710K	155K	430K	32K	374K	525K	70K	115K	59K	109K	163K	209K	0.0	1.2M	1.1M	766K
Total Current Assets	47.3M	36.6M	31M	31.2M	31.2M	22.7M	21.8M	16.2M	11.9M	9.2M	8.4M	8.9M	7.3M	9.5M	11.8M	10.1M	7.3M	10.9M	9.8M	9.3M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.1M	12.7M	13.2M	13.4M	13.4M	5.6M	2.7M	1.8M	1.4M	1.3M	1.5M	1.6M	2.1M	2.5M	3.7M	4.1M	6M	6.5M	3.8M	3.7M
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112K	112K	353K	0.0	0.0	0.0	0.0	0.0	3M	3M	3M	2.9M
Intangible Assets	26K	54K	81K	118K	118K	162K	129K	140K	320K	451K	547K	105K	0.0	0.0	0.0	4.4B	147K	1.2M	1.3M	1.4M
Goodwill & Intangible Assets	26K	54K	81K	118K	118K	162K	129K	140K	432K	563K	900K	105K	-59M	0.0	0.0	4.4B	3.1M	4.2M	4.3M	4.3M
Long-Term Investments	148K	1.6M	7.5M	4.1M	4.1M	2.4M	582K	43K	450K	0.0	1.7M	1.1M	370K	0.0	0.0	0.0	0.0	-2M	0.0	0.0
Tax Assets	1.4M	1.6M	0.0	256K	256K	259K	260K	1.7M	2M	0.0	70K	115K	59M	109M	163M	0.0	0.0	2M	229K	378K
Other Non-Current Assets	11.3M	42K	42K	42K	42K	42K	40K	68K	71K	80K	16K	-38K	813K	-108.2M	-162.9M	-4.4B	87K	68K	25K	44K
Total Non-Current Assets	13.9M	15.9M	20.8M	17.9M	17.9M	8.5M	3.7M	3.7M	4.4M	1.9M	4.1M	2.8M	3.2M	3.3M	3.7M	4.2M	9.2M	10.8M	8.4M	8.5M
Total Assets	61.2M	52.5M	51.8M	49.1M	49.1M	31.1M	25.5M	19.9M	16.4M	11.1M	12.5M	11.7M	10.6M	12.8M	15.6M	14.3M	16.5M	21.7M	18.1M	17.8M
LIABILITIES
CURRENT LIABILITIES
Total Payables	4.8M	5.1M	2.7M	4.3M	4.3M	2M	2M	1.1M	1.2M	849K	1.9M	797K	892K	680K	1.3M	1.4M	880K	1.9M	1.1M	952K
Accounts Payable	4.6M	4.5M	2.3M	3.8M	3.8M	2M	2M	1.1M	1.2M	841K	1.9M	744K	844K	633K	1.2M	1.3M	827K	1.7M	1.1M	952K
Other Payables	186K	632K	453K	544K	544K	0.0	0.0	0.0	9K	8K	0.0	53K	48K	47K	78K	79K	53K	114K	0.0	0.0
Accrued Expenses	1.4M	2.9M	2.7M	2.4M	2.4M	1.3M	1.4M	547K	807K	443K	302K	1.1M	243K	1.4M	2.4M	1.9M	1.4M	2.1M	1.2M	971K
Short Term Debt	6.1M	4.4M	3.8M	3.3M	3.3M	651K	622K	35K	26K	26K	24K	0.0	0.0	774K	357K	435K	433K	2.4M	576K	1.2M
Capital Lease Obligations (Current)	498K	455K	416K	379K	379K	339K	0.0	35K	32K	0.0	7K	8K	5K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	186K	632K	453K	544K	544K	804K	162K	123K	9K	1K	0.0	53K	48K	47K	78K	79K	53K	0.0	202M	-139M
Deferred Revenue	202K	14K	0.0	1M	1M	200K	215K	31K	19K	212K	594K	232K	141K	0.0	0.0	0.0	0.0	2.1M	1.2M	971K
Other Current Liabilities	1.6M	0.0	0.0	0.0	0.0	1.6M	0.0	807K	528K	626K	1.8M	0.0	1M	13K	0.0	0.0	0.0	0.0	240K	71K
Total Current Liabilities	14.6M	12.9M	9.7M	11.4M	11.4M	5.2M	4.3M	2.5M	2.6M	2.1M	3.7M	2.1M	2.3M	2.9M	4M	3.7M	2.7M	6.3M	3.1M	3.2M
NON-CURRENT LIABILITIES
Long Term Debt	9.2M	7.5M	8.9M	10.3M	10.3M	3.3M	3.9M	6K	0.0	46K	70K	0.0	0.0	0.0	774K	2.5M	2.9M	1.6M	2M	2.3M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	-621K	-614K	-476K	-819K	0.0	0.0	-7K	-15K	0.0	0.0	0.0	0.0	0.0	35M	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	8K	0.0	0.0	621K	614K	476K	758K	0.0	70K	115K	59K	109K	163K	209K	171K	290K	-35M	0.0
Other Non-Current Liabilities	0.0	0.0	0.0	0.0	0.0	804K	308K	91K	0.0	147K	204K	243K	270K	284K	279K	255K	212K	194K	158K	245K
Total Non-Current Liabilities	9.9M	8.7M	10.6M	12.3M	12.3M	6.8M	4.2M	103K	61K	193K	344K	365K	344K	393K	1.2M	2.9M	3.3M	2M	2.1M	2.5M
Capital Lease Obligations	1.2M	1.6M	2.1M	2.4M	2.4M	2.8M	0.0	41K	32K	0.0	7K	15K	20K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	24.6M	21.6M	20.2M	23.7M	23.7M	12.1M	8.5M	2.6M	2.6M	2.3M	4M	2.5M	2.7M	3.3M	5.2M	6.7M	6M	8.4M	5.3M	5.7M
SHAREHOLDERS' EQUITY
Common Stock	704K	3.9M	6.8M	7.7M	7.7M	12.8M	15.8M	19.8M	17.7M	18M	18.4M	18.6M	17M	16.8B	16.7B	0.0	0.0	0.0	0.0	0.0
Additional Paid-In Capital	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17M	16.8M	16.7M	16.7M	16.6M	16.5M	16.3M	16.1M
Retained Earnings	35.9M	27M	24.8M	17.7M	17.7M	7.9M	1.7M	-2.4M	-4M	-9.1M	-9.9M	-9.6M	-9.1M	-7.3M	-6.4M	-9.1M	-6.1M	-3.2M	-3.5M	-4M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	-1.6M	-549K	-153K	33K	-7.8M	-7.4M	202K	5K	-6.5M	-6.5M	-5.9M	-5.1M	-4.4M	-3.5M	-3.9M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8M	7.4M	0.0	-17M	-16.8M	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	36.6M	30.9M	31.6M	25.4M	25.4M	19.1M	17M	17.3M	13.7M	8.9M	8.5M	9.2M	7.9M	9.6M	10.3M	7.6M	10.5M	13.3M	12.9M	12.1M
Total Equity	36.6M	30.9M	31.6M	25.4M	25.4M	19.1M	17M	17.3M	13.7M	8.9M	8.5M	9.2M	7.9M	9.6M	10.3M	7.6M	10.5M	13.3M	12.9M	12.1M
SUMMARY
Total Liabilities & Equity	61.2M	52.5M	51.8M	49.1M	49.1M	31.1M	25.5M	19.9M	16.4M	11.1M	12.5M	11.7M	10.6M	12.8M	15.6M	14.3M	16.5M	21.7M	18.1M	17.8M
Total Investments	6.9M	5.8M	8.7M	4.8M	4.8M	4.9M	3.2M	2.2M	718K	0.0	1.7M	1.1M	370K	0.0	0.0	0.0	0.0	-2M	0.0	0.0
Total Debt	16.6M	13.5M	14.8M	16M	16M	6.7M	4.6M	41K	119K	72K	101K	15K	20K	774K	1.1M	2.9M	3.3M	4M	2.6M	3.4M
Net Debt	16.2M	10.9M	11.9M	15.1M	15.1M	263K	-3.2M	-5.1M	-4.1M	-2.2M	-596K	-3.2M	-1.7M	-3.3M	-3.6M	-899K	2.2M	3.5M	2.2M	3.1M
Shares Outstanding	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503	3,261,503

SEC Filings

PDEX - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 30, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 27, 2026	March 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 12, 2026	February 09, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 29, 2026	January 29, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	January 29, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 19, 2025	December 18, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 21, 2025	November 20, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 30, 2025	October 30, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	October 30, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 395 filings

Related Guides

Blog Categories

Continue your PDEX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.